For decades, India's public health response to so-called "poor man's diseases" has been primarily medical. Tablets were supplied, wounds were treated, mosquitos were targeted, and success was measured by decreased infection rates. However, a new World Health Organization (WHO) care package indicates that India has barely treated half of the ailment. 

According to the World Health Organization, the biggest harm to millions of Indians suffering from leprosy and lymphatic filariasis—also known as elephantiasis—is frequently caused by shame, social rejection, and long-term sadness, rather than bacteria or parasites. In a significant shift, the global health organization is now encouraging countries such as India to treat "social exclusion" as a medical emergency, indicating a shift from illness control to what experts call "dignity restoration." 

Every year, India accounts for over 60% of new leprosy cases worldwide, as well as a sizable proportion of lymphatic filariasis patients. These diseases persist primarily in rural and semi-urban areas, where access to healthcare is restricted and social attitudes can be harsh. 

"India's battle against these diseases has focused entirely on the physical," the WHO observes, noting that the new guidance emphasises mental health and social wellness as key components of treatment, not optional extras. 

Why does stigma hurt more than the disease? 

Both leprosy and elephantiasis are curable conditions. Leprosy can be entirely cured with multidrug therapy, whereas elephantiasis can be managed and its progression halted with proper treatment. However, many people postpone treatment for years. 

Is leprosy still common in India? The answer is yes. Despite medical breakthroughs, thousands of new cases are discovered each year, frequently after the fact, because sufferers are afraid of being branded. 

In villages throughout India, a diagnosis can quietly end a life. Marriages are cancelled. Jobs are lost. People are excluded from social occasions. Children are bullied. Over time, this solitude causes anxiety, depression, and, in some cases, suicide ideation. 

"The real killer isn't always the disease itself," observed a public health expert who works with neighbourhood programmes. "It is the moment when a person is ordered not to sit with others, work, or marry. That psychological damage may persist longer than any physical discomfort." 

Another popular query is, "Can elephantiasis be cured?" While the infection can be cured, the oedema induced by long-term lymphatic damage is generally permanent. This obvious handicap becomes a permanent marker, making stigma very impossible to overcome without social help. 

The WHO wants doctors to do things differently

The WHO's new care package calls on governments to strengthen the role of doctors, nurses, and frontline workers. Treating the infection is no longer sufficient. Health providers are encouraged to assess patients for depression, anxiety, and social withdrawal, as well as to actively include families and communities in the rehabilitation process. 

This entails explaining in simple terms that leprosy does not spread by touch once treatment begins and that elephantiasis is caused by mosquito-borne parasites, not curses or personal failures. 

A senior WHO official stated that the guidance acknowledges that "health systems must respond to the human experience of disease, not just the clinical symptoms." 

People frequently question, "Is leprosy contagious?" The truth is that leprosy spreads slowly and is not easily transferred. Once therapy begins, patients are no longer infectious. However, myths continue to dominate public opinion. 

Why this matters for average Indian households 

In the Indian setting, stigma has immediate economic implications. Loss of job drives families deeper into poverty. Rejected marriage proposals affect entire homes, not just individuals. By defining stigma as a health issue, the WHO effectively connects disease prevention with livelihood protection. 

This strategy also aligns with India's growing discussion about mental health. While urban India is increasingly discussing stress and therapy, rural mental health remains mainly invisible. The new WHO approach closes the gap by incorporating mental health treatment into routine illness programmes. 

Another commonly asked topic is, "Why are these diseases called 'poor man's diseases'?" According to experts, this is because they thrive in areas with poor sanitation, housing, and healthcare access. Addressing stigma implies addressing inequity. 

India has made significant progress in lowering illness numbers. However, experts warn that focusing solely on data risks ignoring the lived reality of patients. 

As India rethinks its policy, the WHO's message is clear: treating the physical without addressing the societal damage leaves the task incomplete.